Upcoming scientific meetings endorsed by SOT are featured here.
2020 Exposome Symposium
New York City, New York
March 5–6, 2020
The NYC 2020 Exposome Symposium on “Measuring the Exposome Using Novel Methods and Big Data to Improve Human Health” will be held March 5–6, 2020, in New York. This two-day meeting is organized by the Institute for Exposomic Research at the Icahn School of Medicine at Mount Sinai and will focus on recent developments in data integration, analytical tools, and the potential for usage of exposomics in precision medicine. It will bring together senior and junior research scientists interested in sharing innovative tools that improve exposure data collection and other new methods in the field. Linda Birnbaum, PhD, DABT, ATS, former Director of NIEHS (retired), and Dean Jones, Director of the Clinical Biomarkers Laboratory at Emory University, will give keynote presentations. This year’s program features a poster session for one-on-one personal exchange of research ideas in an informal setting with a unique consortium of participants who are experts in various aspects of exposomics and related fields.
More information can be found on the meeting website.
American College of Toxicology: Toxicology for Pharmaceutical and Regulatory Scientists
March 30–April 3, 2020
Don’t miss the American College of Toxicology’s much-anticipated Toxicology for Pharmaceutical and Regulatory Scientists educational course. This annual ACT course provides basic training in general toxicology. Using pharmaceutical development as an example, participants will obtain an overall understanding of the principles of toxicology and nonclinical safety evaluation. The course will include discussion of regulatory case studies and hands-on analyses of nonclinical data. The course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, CROs, and regulatory agencies, or individuals interested in or currently practicing toxicology.
The course will be held March 30–April 3, 2020, at the Gaithersburg Marriott Washingtonian Center in Gaithersburg, Maryland. Registration is open on the ACT website. Please do not delay in registering for this course, as space is limited and the course has sold out in the past. If you have any questions, please email ACT Headquarters.
Gordon Research Seminar and Conference on Drug Safety
Gordon Research Seminar: Drug Safety
June 13–14, 2020
Gordon Research Conference: Drug Safety
June 14–19, 2020
Adverse events remain a significant hindrance to the drug development process. Thus, it comes as no surprise that improving the science supporting drug safety evaluation is imperative for improvement. To this end, the 2020 Gordon Research Seminar (GRS) on Drug Safety will be held June 13–14, 2020, followed by the Gordon Research Conference (GRC), June 14–19, 2020, at Stonehill College in Easton, Massachusetts.
The GRS will be held in conjunction with the GRC to enhance the Gordon Conference experience for students, trainees, and postdoctoral fellows. The GRS will be chaired by Molly Morgan, University of California San Diego, and Lauren Lewis, Takeda, and is organized for new scientists with a focus on the effectiveness of their scientific presentations. A career development panel will be held to offer career advice and will include leaders from different organizations (government, industry, and academia).
The GRC agenda will mirror the drug development pipeline with topics ranging from in silico computational approaches to clinical trials. The primary goal of the conference is to discuss different strategies to overcome safety challenges in drug discovery and development. Chaired by Myrtle Davis, Bristol-Myers Squibb Company, and Mark Fielden, Expansion Therapeutics, the Drug Safety GRC is a multidisciplinary gathering of scientists from academia, industry, and government. For students and trainees, the conference serves as a career development opportunity and a chance to share their research results with experts in various fields through poster sessions and short talks. Social gatherings each evening allow time for in-depth and informal interactions with leading research scientists.
The registration costs for the GRC and GRS include registration, all meals, and accommodations for the duration of the meeting. What a bargain! We are looking forward to having you attend and participate in these exciting meetings.
For more details and online registrations, please visit the Gordon Research Conference web page, the Gordon Research Seminar web page, or the LinkedIn Group.
International Conference on Heme Oxygenase and Related Enzymes: From Physiology to Therapeutics
Los Angeles, California
June 28–July 1, 2020
Join us for the American Physiological Society’s 11th international conference on Heme Oxygenase and Related Enzymes: From Physiology to Therapeutics, which will be held June 28–July 1, 2020, in Los Angeles. Submit your abstract by April 1 to join the basic, clinical, and translational scientists presenting cutting-edge research in the area of heme oxygenase, related enzymes, and oxidative stress biology. In particular, the axis represented by transcription factor Nrf2 and its target Heme Oxygenase 1 (HO-1) is a major pathway orchestrator of antioxidant responses, playing a major role in cardiovascular and metabolic diseases, inflammatory diseases, cancer biology, and immunology, as well as many other systems. Seize the opportunity to collaborate and discuss the roles of Nrf2, heme oxygenase, and related enzymes in the redox biology underlying each of those specific disorders with researchers in the field.
More information can be found on the meeting website.
Gordon Research Seminar: Thiol-Based Redox Regulation and Signaling
July 11–12, 2020
The Gordon Research Seminar on Thiol-Based Redox Regulation and Signaling is a unique forum for early career scientists to present and exchange new data and cutting-edge ideas. This meeting is ideal for young scientists to extend their scientific network, conceive new ideas, and foster future collaborations. Thiol-based redox modifications take part in many cellular processes, and alterations in the redox pathways are associated with the development and progression of many diseases. This meeting will focus on the basic biochemistry of redox signaling and its functional consequences in physiological and pathophysiological scenarios. Discussion topics include the development of novel tools to study thiol modifications and to monitor and image redox processes in real time.
More information can be found on the meeting web page.